Press Releases
  Date Title View
Jan 28, 2010
WALTHAM, Mass., Jan 28, 2010 (BUSINESS WIRE) -- ImmunoGen, Inc. (Nasdaq: IMGN), a biotechnology company that develops targeted anticancer products using its antibody expertise and Targeted Antibody Payload (TAP) technology, today announced financial results for the three-month period ended December 31, 2009 - the ...
PDF
Jan 21, 2010
WALTHAM, Mass., Jan 21, 2010 (BUSINESS WIRE) -- ImmunoGen, Inc. (Nasdaq: IMGN), a biotechnology company that develops targeted anticancer products, today announced that will host a conference call at 4:30 p.m. ET on Thursday, January 28, 2010 to discuss the Company's financial results for the three-month period ended December 31, 2009 - the seco...
PDF
Jan 6, 2010
WALTHAM, Mass., Jan 06, 2010 (BUSINESS WIRE) -- ImmunoGen, Inc. (Nasdaq: IMGN) is scheduled to present at the 28th Annual J.P. Morgan Healthcare Conference at 9:30 am PST on January 14, 2010. The Conference is being held at the Westin St. Francis hotel in San Francisco, CA. ImmunoGen's presentation will be webcast live and can be accessed throug...
PDF
FirstPrevious ...
14

You are now leaving this website. If you would like to continue, click Continue.
CancelContinue